Menu
GeneBe

IGHMBP2

immunoglobulin mu DNA binding protein 2, the group of UPF1 like RNA helicases|Zinc fingers AN1-type

Basic information

Region (hg38): 11:68903862-68940602

Links

ENSG00000132740NCBI:3508OMIM:600502HGNC:5542Uniprot:P38935AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive distal spinal muscular atrophy 1 (Definitive), mode of inheritance: AR
  • autosomal recessive distal spinal muscular atrophy 1 (Strong), mode of inheritance: AR
  • autosomal recessive distal spinal muscular atrophy 1 (Definitive), mode of inheritance: AR
  • Charcot-Marie-Tooth disease axonal type 2S (Strong), mode of inheritance: AR
  • autosomal recessive distal spinal muscular atrophy 1 (Supportive), mode of inheritance: AR
  • Charcot-Marie-Tooth disease axonal type 2S (Supportive), mode of inheritance: AR
  • Charcot-Marie-Tooth disease axonal type 2S (Definitive), mode of inheritance: AR
  • Charcot-Marie-Tooth disease axonal type 2S (Strong), mode of inheritance: AR
  • autosomal recessive distal spinal muscular atrophy 1 (Strong), mode of inheritance: AR
  • hereditary peripheral neuropathy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neuronopathy, distal hereditary motor, autosomal recessive 1; Charcot-Marie-Tooth disease, axonal, type 2SARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic11528396; 14681881; 15290238; 16458836; 16765827; 17431882; 20859832; 21353777; 22157136; 25439726; 25568292

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IGHMBP2 gene.

  • Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 (408 variants)
  • Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S (381 variants)
  • not provided (336 variants)
  • Inborn genetic diseases (226 variants)
  • Autosomal recessive distal spinal muscular atrophy 1 (182 variants)
  • Charcot-Marie-Tooth disease (144 variants)
  • not specified (100 variants)
  • Charcot-Marie-Tooth disease axonal type 2S (39 variants)
  • Neuronopathy, distal hereditary motor, autosomal dominant (20 variants)
  • Distal spinal muscular atrophy (20 variants)
  • Peripheral neuropathy (3 variants)
  • Spinal muscular atrophy (3 variants)
  • IGHMBP2-related disorders (2 variants)
  • IGHMBP2-related condition (2 variants)
  • Neurodevelopmental disorder (2 variants)
  • Progressive muscle weakness;Lower limb muscle weakness;Hammertoe;Difficulty walking;Inability to walk (2 variants)
  • Neuronopathy, distal hereditary motor, autosomal dominant 1 (1 variants)
  • 7 conditions (1 variants)
  • Charcot-Marie-Tooth disease, type I (1 variants)
  • IGHMBP2-related neuronopathy (1 variants)
  • Autosomal dominant intermediate Charcot-Marie-Tooth disease (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGHMBP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
181
clinvar
5
clinvar
195
missense
7
clinvar
17
clinvar
429
clinvar
13
clinvar
9
clinvar
475
nonsense
18
clinvar
6
clinvar
24
start loss
1
clinvar
1
frameshift
26
clinvar
9
clinvar
35
inframe indel
5
clinvar
5
splice donor/acceptor (+/-2bp)
6
clinvar
10
clinvar
1
clinvar
17
splice region
2
13
19
1
35
non coding
1
clinvar
29
clinvar
94
clinvar
48
clinvar
172
Total 58 43 473 288 62

Highest pathogenic variant AF is 0.0000919

Variants in IGHMBP2

This is a list of pathogenic ClinVar variants found in the IGHMBP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-68903885-T-C Autosomal recessive distal spinal muscular atrophy 1 Benign (Jan 13, 2018)305827
11-68903904-G-C not specified Likely benign (Oct 23, 2017)512775
11-68903919-C-G not specified Likely benign (Oct 27, 2017)388783
11-68903923-G-C not specified Likely benign (Mar 21, 2017)379725
11-68903925-C-A Autosomal recessive distal spinal muscular atrophy 1 • not specified Benign (Jan 13, 2018)305828
11-68903928-C-T not specified Likely benign (Oct 20, 2016)389694
11-68903939-G-C not specified Likely benign (Apr 27, 2017)509231
11-68903948-C-T Uncertain significance (Jun 01, 2016)806710
11-68903949-G-A Spinal muscular atrophy Uncertain significance (Jun 14, 2016)305829
11-68903951-C-T not specified • Autosomal recessive distal spinal muscular atrophy 1 • Charcot-Marie-Tooth disease • Charcot-Marie-Tooth disease axonal type 2S Benign (Aug 10, 2021)258555
11-68903954-T-C Autosomal recessive distal spinal muscular atrophy 1 • Inborn genetic diseases • Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Pathogenic/Likely pathogenic (Aug 04, 2023)217448
11-68903956-G-A Charcot-Marie-Tooth disease • Inborn genetic diseases Uncertain significance (Mar 11, 2021)917101
11-68903956-G-T Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S • Inborn genetic diseases Uncertain significance (Mar 14, 2023)466595
11-68903958-C-T Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Likely benign (Apr 03, 2018)757423
11-68903959-T-G Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Uncertain significance (Aug 31, 2022)569975
11-68903962-G-A not specified Uncertain significance (Nov 02, 2016)439818
11-68903964-A-G Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S Likely benign (Sep 18, 2023)2413502
11-68903967-T-A Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Likely benign (Oct 04, 2023)2935675
11-68903986-A-ACC Spinal muscular atrophy Likely pathogenic (Jun 17, 2019)986345
11-68903988-G-A Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S Likely benign (Nov 15, 2023)2929993
11-68903988-G-T Charcot-Marie-Tooth disease Benign (-)916742
11-68903991-A-G Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Likely benign (Apr 08, 2023)2943661
11-68903998-C-G Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S Uncertain significance (Nov 14, 2023)2930359
11-68903998-C-T Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 Likely benign (May 18, 2023)2937689
11-68904002-T-C Distal spinal muscular atrophy Uncertain significance (-)637458

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IGHMBP2protein_codingprotein_codingENST00000255078 1536761
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.02e-160.63112560701411257480.000561
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1765805920.9800.00003996378
Missense in Polyphen192207.340.926042161
Synonymous-1.402872581.110.00001882081
Loss of Function1.813143.90.7060.00000283464

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005730.000570
Ashkenazi Jewish0.0002980.000298
East Asian0.0008210.000816
Finnish0.0004680.000416
European (Non-Finnish)0.0007520.000721
Middle Eastern0.0008210.000816
South Asian0.0006210.000425
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: 5' to 3' helicase that unwinds RNA and DNA duplices in an ATP-dependent reaction. Acts as a transcription regulator. Required for the transcriptional activation of the flounder liver- type antifreeze protein gene. Exhibits strong binding specificity to the enhancer element B of the flounder antifreeze protein gene intron. Binds to the insulin II gene RIPE3B enhancer region. May be involved in translation (By similarity). DNA-binding protein specific to 5'-phosphorylated single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region. Preferentially binds to the 5'-GGGCT-3' motif. Interacts with tRNA-Tyr. Stimulates the transcription of the human neurotropic virus JCV. {ECO:0000250, ECO:0000269|PubMed:19158098, ECO:0000269|PubMed:19299493}.;
Disease
DISEASE: Charcot-Marie-Tooth disease 2S (CMT2S) [MIM:616155]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:25439726}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.199

Intolerance Scores

loftool
0.0776
rvis_EVS
0.86
rvis_percentile_EVS
88.57

Haploinsufficiency Scores

pHI
0.102
hipred
N
hipred_score
0.414
ghis
0.471

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.818

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ighmbp2
Phenotype
growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
DNA replication;DNA repair;DNA recombination;translation;DNA duplex unwinding;protein homooligomerization
Cellular component
nucleus;cytoplasm;membrane;axon;growth cone;ribonucleoprotein complex
Molecular function
tRNA binding;DNA binding;DNA helicase activity;single-stranded DNA binding;RNA binding;protein binding;ATP binding;DNA-dependent ATPase activity;transcription factor binding;RNA-dependent ATPase activity;zinc ion binding;ATP-dependent 5'-3' RNA helicase activity;ribosome binding;ATP-dependent 5'-3' DNA helicase activity